Free Trial
NASDAQ:EQ

Equillium (EQ) Stock Price, News & Analysis

Equillium logo
$1.91 -0.04 (-2.05%)
Closing price 04:00 PM Eastern
Extended Trading
$1.87 -0.04 (-2.09%)
As of 06:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Equillium Stock (NASDAQ:EQ)

Key Stats

Today's Range
$1.70
$2.00
50-Day Range
$0.29
$1.95
52-Week Range
$0.27
$2.26
Volume
1.84 million shs
Average Volume
3.50 million shs
Market Capitalization
$113.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.00
Consensus Rating
Hold

Company Overview

Equillium Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
22nd Percentile Overall Score

EQ MarketRank™: 

Equillium scored higher than 22% of companies evaluated by MarketBeat, and ranked 861st out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Equillium has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Equillium has received no research coverage in the past 90 days.

  • Read more about Equillium's stock forecast and price target.
  • Earnings Growth

    Earnings for Equillium are expected to decrease in the coming year, from $0.14 to ($0.81) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Equillium is -3.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Equillium is -3.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Equillium has a P/B Ratio of 23.88. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Equillium's valuation and earnings.
  • Percentage of Shares Shorted

    2.43% of the float of Equillium has been sold short.
  • Short Interest Ratio / Days to Cover

    Equillium has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Equillium has recently decreased by 53.10%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Equillium does not currently pay a dividend.

  • Dividend Growth

    Equillium does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.43% of the float of Equillium has been sold short.
  • Short Interest Ratio / Days to Cover

    Equillium has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Equillium has recently decreased by 53.10%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Equillium has a news sentiment score of 0.81. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.97 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Equillium this week, compared to 1 article on an average week.
  • Search Interest

    15 people have searched for EQ on MarketBeat in the last 30 days. This is an increase of 400% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added Equillium to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Equillium insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    30.30% of the stock of Equillium is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 27.05% of the stock of Equillium is held by institutions.

  • Read more about Equillium's insider trading history.
Receive EQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Equillium and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EQ Stock News Headlines

Financial Review: Equillium (NASDAQ:EQ) and Imunon (NASDAQ:IMNN)
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.tc pixel
Equillium Secures $30 Million in Private Placement
See More Headlines

EQ Stock Analysis - Frequently Asked Questions

Equillium's stock was trading at $0.7482 on January 1st, 2025. Since then, EQ shares have increased by 155.3% and is now trading at $1.91.

Equillium, Inc. (NASDAQ:EQ) posted its quarterly earnings data on Thursday, August, 14th. The company reported ($0.16) earnings per share for the quarter, missing analysts' consensus estimates of ($0.14) by $0.02. Equillium had a negative net margin of 19.62% and a negative trailing twelve-month return on equity of 139.56%.

Equillium (EQ) raised $70 million in an initial public offering on Friday, October 12th 2018. The company issued 4,700,000 shares at a price of $14.00-$16.00 per share. Jefferies, Leerink Partners and Stifel served as the underwriters for the IPO.

Shares of EQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Equillium investors own include NVIDIA (NVDA), Meta Platforms (META), Bank of America (BAC), Advanced Micro Devices (AMD), AbbVie (ABBV), Tilray Brands (TLRY) and Carnival (CCL).

Company Calendar

Last Earnings
8/14/2025
Today
8/27/2025
Next Earnings (Estimated)
11/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:EQ
CIK
1746466
Fax
N/A
Employees
40
Year Founded
N/A

Price Target and Rating

High Price Target
$1.00
Low Price Target
$1.00
Potential Upside/Downside
-48.7%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.56)
Trailing P/E Ratio
N/A
Forward P/E Ratio
13.93
P/E Growth
N/A
Net Income
-$8.07 million
Net Margins
-19.62%
Pretax Margin
-119.82%
Return on Equity
-139.56%
Return on Assets
-90.56%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.65
Quick Ratio
1.65

Sales & Book Value

Annual Sales
$41.10 million
Price / Sales
2.82
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.08 per share
Price / Book
24.38

Miscellaneous

Outstanding Shares
59,500,000
Free Float
41,474,000
Market Cap
$116.03 million
Optionable
Not Optionable
Beta
1.15

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:EQ) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners